The multidisciplinary UAB Training Program in Brain Tumor Biology trains highly motivated predoctoral students and Ph.D. and M.D. graduates in the fields of fundamental and translational brain tumor biology. The program builds on the interdisciplinary basic and translational investigative efforts supported by the Neuro- Oncology Program and the UAB Brain Tumor SPORE Grant. Seventeen faculty members serve as mentors on this training program. Key partners are the thematically based Graduate Biomedical Sciences Program, the UAB MSTP Program and the Office of Postdoctoral Education. The Brain Tumor Training Program incorporates faculty committed to training in the fields of oncolytic properties of mutant herpes viruses, novel clinical applications of monoclonal antibody therapy, signal transduction pathways, systems biology, bioinformatics, genomics, kinomics, innate immune response, glioma stem cells, invasive and angiogenic mechanisms, bio-energetics and oxidative stress. An effective interdisciplinary training program requires faculty with collaborative and synergistic scientific interests. A Pub-Med search of the 17 mentors revealed that 95% published with at least one other mentor. This committed training environment provides an ideal setting for the implementation of interdisciplinary research and training. Over the last five years, 8 postdoctoral and 6 predoctoral trainees have been supported, with 13 of 14 continuing in biomedical research, teaching and/or training. The success of this program is evident by the outstanding publication record of the trainees, having published 48 peer-reviewed manuscripts in highly competitive journals, with an additional 11 under review or in preparation. A major effort has been made to recruit under-represented minorities and to enhance gender equality among the trainees. Our trainees have been 57% male (8/14) and 43% female (6/14), and have included 22% under-represented minorities (3/14;African American and Hispanic American). They have trained with 10 primary or co-mentors from 7 departments. Because a large number of our mentors are involved in patient care in addition to their research activities, the program provides a strong interface between basic and applied brain tumor biology. The Training Program provides an exceptional interdisciplinary environment in terms of didactic training and enrichment opportunities. The didactic component encompasses the Advanced Course in Brain Tumor Biology, a new course entitled Brain Tumor Clinical Course, and a new "hand-on" TCGA/Bioinformatics Tutorial. Enrichment activities include a new Monthly Research-In-Progress Brain Tumor Conference, a Monthly Brain Tumor Research Seminar Series, and the Annual UAB Brain Tumor SPORE Scientific Retreat. Collectively, the research training, didactic training and enrichment activities will ensure the development of the next generation of basic/translational researchers addressing the compelling problems related to brain tumors.
The multidisciplinary UAB Training Program in Brain Tumor Biology is focused on training highly motivated predoctoral students and Ph.D. and M.D. graduates in the fields of translational and fundamental brain tumor biology. Our trainees are selected for their commitment to research and academic medicine. Our committed training environment provides the ideal setting for the implementation of interdisciplinary research and training to allow our trainees to succeed in their future research endeavors.
|Robert, Stephanie M; Sontheimer, Harald (2014) Glutamate transporters in the biology of malignant gliomas. Cell Mol Life Sci 71:1839-54|
|Robert, Stephanie M; Ogunrinu-Babarinde, Toyin; Holt, Kenneth T et al. (2014) Role of glutamate transporters in redox homeostasis of the brain. Neurochem Int 73:181-91|
|McFarland, Braden C; Gray, G Kenneth; Nozell, Susan E et al. (2013) Activation of the NF-*B pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells. Mol Cancer Res 11:494-505|
|Markert, James M; Cody, James J; Parker, Jacqueline N et al. (2012) Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12. J Virol 86:5304-13|
|Buckingham, Susan C; Campbell, Susan L; Haas, Brian R et al. (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17:1269-74|
|McFarland, Braden C; Ma, Jing-Yuan; Langford, Catherine P et al. (2011) Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Mol Cancer Ther 10:2384-93|
|Baker, Brandi J; Park, Keun W; Qin, Hongwei et al. (2010) IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia 58:1082-93|
|Ma, Xiangyu; Reynolds, Stephanie L; Baker, Brandi J et al. (2010) IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol 184:4898-906|
|Lai, Yun-Ju; Lin, Victor T G; Zheng, Ying et al. (2010) The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration. Mol Cell Biol 30:5582-96|
|Baker, Brandi J; Akhtar, Lisa Nowoslawski; Benveniste, Etty N (2009) SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 30:392-400|
Showing the most recent 10 out of 13 publications